A detailed history of Daiwa Securities Group Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 529 shares of DVAX stock, worth $7,083. This represents 0.0% of its overall portfolio holdings.

Number of Shares
529
Previous 379 39.58%
Holding current value
$7,083
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$10.05 - $11.61 $1,507 - $1,741
150 Added 39.58%
529 $6,000
Q2 2024

Aug 07, 2024

SELL
$10.73 - $12.58 $1,609 - $1,887
-150 Reduced 28.36%
379 $4,000
Q4 2023

Jan 31, 2024

BUY
$13.09 - $14.98 $6,924 - $7,924
529 New
529 $7,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.69B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.